 |
|
|
| |
Phase 3 Efficacy and Safety of Switch From
B/F/TAF to Single-Tablet BIC/LEN in ARTISTRY-2
|
| |
| |
CROI 2026 Denver Feb 22-25
Eric G Meissner1, Moti Ramgopal2, Peter J Ruane3, William Sanchez4, Jean-Pierre Routy5, Mark O’Reilly6, Sergio Lupo7, Sven Schellberg8, Keith Aizen9, Hailin Huang9, Kwad Mponponsuo9, Peter Sklar9, Martin Rhee9, Chien-Ching Hung10
1Medical University of South Carolina, Charleston, SC, USA; 2Midway Immunology and Research Center, Fort Pierce, FL, USA; 3Ruane Clinical Research Group, Los Angeles, CA, USA; 4Floridian Clinical Research, Miami Lakes, FL, USA; 5McGill University Health Centre, Montreal, QC, Canada;
6Taylor Square Private Clinic, Sydney, NSW, Australia; 7CAICI, Rosario, Argentina; 8Novopraxis Berlin GbR, Berlin, Germany; 9Gilead Sciences, Inc., Foster City, CA, USA; 10National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan
|
| |
|
|
|
|
|
